Interferon gamma: A master regulator of atherosclerosis

Cytokine and Growth Factor Reviews

Volumn 20, Issue 2, 2009, Pages 125-135

  McLaren, James E ^a   Ramji, Dipak P ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Atherosclerosis; Foam cell formation; Interferon ; Th1 immune response

Indexed keywords

GAMMA INTERFERON;

ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CHRONIC INFLAMMATION; HUMAN; IMMUNOPATHOGENESIS; IMMUNOREGULATION; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; ATHEROSCLEROSIS; DISEASE MODELS, ANIMAL; FOAM CELLS; INFLAMMATION; INTERFERON-GAMMA; MICE;

EID: 63749108516     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2008.11.003     Document Type: Review

References (100)

1. Lusis A.J. Atherosclerosis. Nature 407 6801 (2000) 233-241
2. Lusis A.J., Mar R., and Pajukanta P. Genetics of atherosclerosis. Ann Rev Genomics Hum Genet 5 (2004) 189-218
3. Li A.C., and Glass C.K. The macrophage foam cell as a target for therapeutic intervention. Nat Med 8 11 (2002) 1235-1242
4. Shashkin P., Dragulev B., and Ley K. Macrophage differentiation to foam cells. Curr Pharm Des 11 23 (2005) 3061-3072
5. Goldstein J.L., Ho Y.K., Basu S.K., and Brown M.S. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci U S A 76 1 (1979) 333-337
6. Hansson G.K., Jonasson L., Holm J., and Claesson-Welsh L. Class II MHC antigen expression in the atherosclerotic plaque: smooth muscle cells express HLA-DR, HLA-DQ and the invariant gamma chain. Clin Exp Immunol 64 2 (1986) 261-268
7. Reardon C.A., Blachowicz L., White T., Cabana V., Wang Y., Lukens J., et al. Effect of immune deficiency on lipoproteins and atherosclerosis in male apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 21 6 (2001) 1011-1016
8. Zhou X., Nicoletti A., Elhage R., and Hansson G.K. Transfer of CD4(+) T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice. Circulation 102 24 (2000) 2919-2922
9. Tedgui A., and Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 86 2 (2006) 515-581
10. Mehra V.C., Ramgolam V.S., and Bender J.R. Cytokines and cardiovascular disease. J Leukoc Biol 78 4 (2005) 805-818
11. Young J.L., Libby P., and Schonbeck U. Cytokines in the pathogenesis of atherosclerosis. Thromb Haemost 88 4 (2002) 554-567
12. van Boxel-Dezaire A.H., and Stark G.R. Cell type-specific signaling in response to interferon-gamma. Curr Top Microbiol Immunol 316 (2007) 119-154
13. Mosmann T.R., and Coffman R.L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Ann Rev Immunol 7 (1989) 145-173
14. Sad S., Marcotte R., and Mosmann T.R. Cytokine-induced differentiation of precursor mouse CD8+ T cells into cytotoxic CD8+ T cells secreting Th1 or Th2 cytokines. Immunity 2 3 (1995) 271-279
15. Munder M., Mallo M., Eichmann K., and Modolell M. Murine macrophages secrete interferon gamma upon combined stimulation with interleukin(IL)-12 and IL-18: a novel pathway of autocrine macrophage activation. J Exp Med 187 12 (1998) 2103-2108
16. Bancroft G.J., Schreiber R.D., and Unanue E.R. Natural immunity: a T-cell-independent pathway of macrophage activation, defined in the scid mouse. Immunol Rev 124 (1991) 5-24
17. Flaishon L., Hershkoviz R., Lantner F., Lider O., Alon R., Levo Y., et al. Autocrine secretion of interferon gamma negatively regulates homing of immature B cells. J Exp Med 192 9 (2000) 1381-1388
18. Mire-Sluis A., and Thorpe R. Cytokines (1998), Academic press, London
19. Darnell Jr. J.E., Kerr I.M., and Stark G.R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264 5164 (1994) 1415-1421
20. Levy D.E., and Darnell Jr. J.E. Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol 3 9 (2002) 651-662
21. Igarashi K., Garotta G., Ozmen L., Ziemiecki A., Wilks A.F., Harpur A.G., et al. Interferon-gamma induces tyrosine phosphorylation of interferon-gamma receptor and regulated association of protein tyrosine kinases, Jak1 and Jak2, with its receptor. J Biol Chem 269 20 (1994) 14333-14336
22. Sakatsume M., Igarashi K., Winestock K.D., Garotta G., Larner A.C., and Finbloom D.S. The Jak kinases differentially associate with the alpha and beta(accessory factor) chains of the interferon gamma receptor to form a functional receptor unit capable of activating STAT transcription factors. J Biol Chem 270 29 (1995) 17528-17534
23. Briscoe J., Rogers N.C., Witthuhn B.A., Watling D., Harpur A.G., Wilks A.F., et al. Kinase-negative mutants of JAK1 can sustain interferon-gamma-inducible gene expression but not an antiviral state. EMBOJ 15 4 (1996) 799-809
24. Greenlund A.C., Morales M.O., Viviano B.L., Yan H., Krolewski J., and Schreiber R.D. Stat recruitment by tyrosine-phosphorylated cytokine receptors: an ordered reversible affinity-driven process. Immunity 2 6 (1995) 677-687
25. Shuai K., Horvath C.M., Huang L.H., Qureshi S.A., Cowburn D., and Darnell Jr. J.E. Interferon activation of the transcription factor Stat91 involves dimerization through SH2-phosphotyrosyl peptide interactions. Cell 76 5 (1994) 821-828
26. Ramana C.V., Gil M.P., Schreiber R.D., and Stark G.R. Stat1-dependent and -independent pathways in IFN-gamma-dependent signaling. Trends Immunol 23 2 (2002) 96-101
27. Mead J.R., Hughes T.R., Irvine S.A., Singh N.N., and Ramji D.P. Interferon-gamma stimulates the expression of the inducible cAMP early repressor in macrophages through the activation of casein kinase 2. A potentially novel pathway for interferon-gamma-mediated inhibition of gene transcription. J Biol Chem 278 20 (2003) 17741-17751
28. Gough D.J., Sabapathy K., Ko E.Y., Arthur H.A., Schreiber R.D., Trapani J.A., et al. A novel c-Jun-dependent signal transduction pathway necessary for the transcriptional activation of interferon gamma response genes. J Biol Chem 282 2 (2007) 938-946
29. Muhl H., and Pfeilschifter J. Anti-inflammatory properties of pro-inflammatory interferon-gamma. Int Immunopharmacol 3 9 (2003) 1247-1255
30. Ehrt S., Schnappinger D., Bekiranov S., Drenkow J., Shi S., Gingeras T.R., et al. Reprogramming of the macrophage transcriptome in response to interferon-gamma and Mycobacterium tuberculosis: signaling roles of nitric oxide synthase-2 and phagocyte oxidase. J Exp Med 194 8 (2001) 1123-1140
31. Greaves D.R., Gough P.J., and Gordon S. Recent progress in defining the role of scavenger receptors in lipid transport, atherosclerosis and host defence. Curr Opin Lipidol 9 5 (1998) 425-432
32. Shimaoka T., Kume N., Minami M., Hayashida K., Kataoka H., Kita T., et al. Molecular cloning of a novel scavenger receptor for oxidized low density lipoprotein, SR-PSOX, on macrophages. J Biol Chemistry 275 52 (2000) 40663-40666
33. Geng Y.J., and Hansson G.K. Interferon-gamma inhibits scavenger receptor expression and foam cell formation in human monocyte-derived macrophages. J Clin Invest 89 4 (1992) 1322-1330
34. Nakagawa T., Nozaki S., Nishida M., Yakub J.M., Tomiyama Y., Nakata A., et al. Oxidized LDL increases and interferon-gamma decreases expression of CD36 in human monocyte-derived macrophages. Arterioscler Thromb Vasc Biol 18 8 (1998) 1350-1357
35. Agrawal S., Febbraio M., Podrez E., Cathcart M.K., Stark G.R., and Chisolm G.M. Signal transducer and activator of transcription 1 is required for optimal foam cell formation and atherosclerotic lesion development. Circulation 115 23 (2007) 2939-2947
36. Wuttge D.M., Zhou X., Sheikine Y., Wagsater D., Stemme V., Hedin U., et al. CXCL16/SR-PSOX is an interferon-gamma-regulated chemokine and scavenger receptor expressed in atherosclerotic lesions. Arterioscler Thromb Vasc Biol 24 4 (2004) 750-755
37. Reiss A.B., Patel C.A., Rahman M.M., Chan E.S., Hasneen K., Montesinos M.C., et al. Interferon-gamma impedes reverse cholesterol transport and promotes foam cell transformation in THP-1 human monocytes/macrophages. Med Sci Monit 10 11 (2004) BR420-BR425
38. Grewal T., Priceputu E., Davignon J., and Bernier L. Identification of a gamma-interferon-responsive element in the promoter of the human macrophage scavenger receptor A gene. Arterioscler Thromb Vasc Biol 21 5 (2001) 825-831
39. Li H., Freeman M.W., and Libby P. Regulation of smooth muscle cell scavenger receptor expression in vivo by atherogenic diets and in vitro by cytokines. J Clin Invest 95 1 (1995) 122-133
40. Wagsater D., Olofsson P.S., Norgren L., Stenberg B., and Sirsjo A. The chemokine and scavenger receptor CXCL16/SR-PSOX is expressed in human vascular smooth muscle cells and is induced by interferon gamma. Biochem Biophys Res Commun 325 4 (2004) 1187-1193
41. Mendez A.J. Cholesterol efflux mediated by apolipoproteins is an active cellular process distinct from efflux mediated by passive diffusion. J Lipid Res 38 9 (1997) 1807-1821
42. Oram J.F., and Heinecke J.W. ATP-binding cassette transporter A1: a cell cholesterol exporter that protects against cardiovascular disease. Physiol Rev 85 4 (2005) 1343-1372
43. Panousis C.G., and Zuckerman S.H. Interferon-gamma induces downregulation of Tangier disease gene (ATP-binding-cassette transporter 1) in macrophage-derived foam cells. Arterioscler Thromb Vasc Biol 20 6 (2000) 1565-1571
44. Wang X.Q., Panousis C.G., Alfaro M.L., Evans G.F., and Zuckerman S.H. Interferon-gamma-mediated downregulation of cholesterol efflux and ABC1 expression is by the Stat1 pathway. Arterioscler Thromb Vasc Biol 22 5 (2002) e5-9
45. Reiss A.B., Awadallah N.W., Malhotra S., Montesinos M.C., Chan E.S., Javitt N.B., et al. Immune complexes and IFN-gamma decrease cholesterol 27-hydroxylase in human arterial endothelium and macrophages. J Lipid Res 42 11 (2001) 1913-1922
46. Bjorkhem I., Andersson O., Diczfalusy U., Sevastik B., Xiu R.J., Duan C., et al. Atherosclerosis and sterol 27-hydroxylase: evidence for a role of this enzyme in elimination of cholesterol from human macrophages. Proc Natl Acad Sci U S A 91 18 (1994) 8592-8596
47. Brand K., Mackman N., and Curtiss L.K. Interferon-gamma inhibits macrophage apolipoprotein E production by posttranslational mechanisms. J Clin Invest 91 5 (1993) 2031-2039
48. Greenow K., Pearce N.J., and Ramji D.P. The key role of apolipoprotein E in atherosclerosis. J Mol Med 83 5 (2005) 329-342
49. Mead J.R., and Ramji D.P. The pivotal role of lipoprotein lipase in atherosclerosis. Cardiovasc Res 55 2 (2002) 261-269
50. Jonasson L., Hansson G.K., Bondjers G., Noe L., and Etienne J. Interferon-gamma inhibits lipoprotein lipase in human monocyte-derived macrophages. Biochim Biophys Acta 1053 1 (1990) 43-48
51. Hughes T.R., Tengku-Muhammad T.S., Irvine S.A., and Ramji D.P. A novel role of Sp1 and Sp3 in the interferon-gamma-mediated suppression of macrophage lipoprotein lipase gene transcription. J Biol Chem 277 13 (2002) 11097-11106
52. Jessup W., and Dean R.T. Autoinhibition of murine macrophage-mediated oxidation of low-density lipoprotein by nitric oxide synthesis. Atherosclerosis 101 2 (1993) 145-155
53. Christen S., Thomas S.R., Garner B., and Stocker R. Inhibition by interferon-gamma of human mononuclear cell-mediated low density lipoprotein oxidation. Participation of tryptophan metabolism along the kynurenine pathway. J Clin Invest 93 5 (1994) 2149-2158
54. Fong L.G., Albert T.S., and Hom S.E. Inhibition of the macrophage-induced oxidation of low density lipoprotein by interferon-gamma. J Lipid Res 35 5 (1994) 893-904
55. Folcik V.A., Aamir R., and Cathcart M.K. Cytokine modulation of LDL oxidation by activated human monocytes. Arterioscler Thromb Vasc Biol 17 10 (1997) 1954-1961
56. Gupta S., Pablo A.M., Jiang X., Wang N., Tall A.R., and Schindler C. IFN-gamma potentiates atherosclerosis in ApoE knock-out mice. J Clin Invest 99 11 (1997) 2752-2761
57. Boisvert W.A. Modulation of atherogenesis by chemokines. Trends Cardiovasc Med 14 4 (2004) 161-165
58. Charo I.F., and Taubman M.B. Chemokines in the pathogenesis of vascular disease. Circ Res 95 9 (2004) 858-866
59. Harvey E.J., Li N., and Ramji D.P. Critical role for casein kinase 2 and phosphoinositide-3-kinase in the interferon-gamma-induced expression of monocyte chemoattractant protein-1 and other key genes implicated in atherosclerosis. Arterioscler Thromb Vasc Biol 27 4 (2007) 806-812
60. Aiello R.J., Bourassa P.A., Lindsey S., Weng W., Natoli E., Rollins B.J., et al. Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 19 6 (1999) 1518-1525
61. Galkina E., Harry B.L., Ludwig A., Liehn E.A., Sanders J.M., Bruce A., et al. CXCR6 promotes atherosclerosis by supporting T-cell homing, interferon-gamma production, and macrophage accumulation in the aortic wall. Circulation 116 16 (2007) 1801-1811
62. Li H., Cybulsky M.I., Gimbrone Jr. M.A., and Libby P. Inducible expression of vascular cell adhesion molecule-1 by vascular smooth muscle cells in vitro and within rabbit atheroma. Am J Pathol 143 6 (1993) 1551-1559
63. Chung H.K., Lee I.K., Kang H., Suh J.M., Kim H., Park K.C., et al. Statin inhibits interferon-gamma-induced expression of intercellular adhesion molecule-1(ICAM-1) in vascular endothelial and smooth muscle cells. Exp Mol Med 34 6 (2002) 451-461
64. Hansson G.K., and Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 6 7 (2006) 508-519
65. Stemme S., Faber B., Holm J., Wiklund O., Witztum J.L., and Hansson G.K. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc Natl Acad Sci U S A 92 9 (1995) 3893-3897
66. Nicoletti A., Caligiuri G., Tornberg I., Kodama T., Stemme S., and Hansson G.K. The macrophage scavenger receptor type A directs modified proteins to antigen presentation. Eur J Immunol 29 2 (1999) 512-521
67. Wong G.H., Clark-Lewis I., McKimm-Breschkin L., Harris A.W., and Schrader J.W. Interferon-gamma induces enhanced expression of Ia and H-2 antigens on B lymphoid, macrophage, and myeloid cell lines. J Immunol 131 2 (1983) 788-793
68. Stemme S., Fager G., and Hansson G.K. MHC class II antigen expression in human vascular smooth muscle cells is induced by interferon-gamma and modulated by tumour necrosis factor and lymphotoxin. Immunology 69 2 (1990) 243-249
69. Manyak C.L., Tse H., Fischer P., Coker L., Sigal N.H., and Koo G.C. Regulation of class II MHC molecules on human endothelial cells. Effects of IFN and dexamethasone. J Immunol 140 11 (1988) 3817-3821
70. Gotsman I., Grabie N., Gupta R., Dacosta R., MacConmara M., Lederer J., et al. Impaired regulatory T-cell response and enhanced atherosclerosis in the absence of inducible costimulatory molecule. Circulation 114 19 (2006) 2047-2055
71. Zhou X., Robertson A.K., Hjerpe C., and Hansson G.K. Adoptive transfer of CD4+ T cells reactive to modified low-density lipoprotein aggravates atherosclerosis. Arterioscler Thromb Vasc Biol 26 4 (2006) 864-870
72. Alderson M.R., Armitage R.J., Tough T.W., Strockbine L., Fanslow W.C., and Spriggs M.K. CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40. J Exp Med 178 2 (1993) 669-674
73. Nguyen V.T., and Benveniste E.N. Involvement of STAT-1 and ets family members in interferon-gamma induction of CD40 transcription in microglia/macrophages. J Biol Chem 275 31 (2000) 23674-23684
74. Mallat Z., Ait-Oufella H., and Tedgui A. Regulatory T-cell immunity in atherosclerosis. Trends Cardiovascr Med 17 4 (2007) 113-118
75. Nishikawa H., Kato T., Tawara I., Ikeda H., Kuribayashi K., Allen P.M., et al. IFN-gamma controls the generation/activation of CD4+ CD25+ regulatory T cells in antitumor immune response. J Immunol 175 7 (2005) 4433-4440
76. Nakai Y., Iwabuchi K., Fujii S., Ishimori N., Dashtsoodol N., Watano K., et al. Natural killer T cells accelerate atherogenesis in mice. Blood 104 7 (2004) 2051-2059
77. Aslanian A.M., Chapman H.A., and Charo I.F. Transient role for CD1d-restricted natural killer T cells in the formation of atherosclerotic lesions. Arterioscler Thromb Vasc Biol 25 3 (2005) 628-632
78. Tupin E., Nicoletti A., Elhage R., Rudling M., Ljunggren H.G., Hansson G.K., et al. CD1d-dependent activation of NKT cells aggravates atherosclerosis. J Exp Med 199 3 (2004) 417-422
79. Sun J., Sukhova G.K., Wolters P.J., Yang M., Kitamoto S., Libby P., et al. Mast cells promote atherosclerosis by releasing proinflammatory cytokines. Nat Med 13 6 (2007) 719-724
80. Rogers L., Burchat S., Gage J., Hasu M., Thabet M., Wilcox L., et al. Deficiency of invariant V alpha 14 natural killer T cells decreases atherosclerosis in LDL receptor null mice. Cardiovasc Res 78 1 (2008) 167-174
81. Esteban L., Vidal M., and Dusso A. 1alpha-Hydroxylase transactivation by gamma-interferon in murine macrophages requires enhanced C/EBPbeta expression and activation. J Steroid Biochem Mol Biol 89-90 1-5 (2004) 131-137
82. Inagaki Y., Yamagishi S., Amano S., Okamoto T., Koga K., and Makita Z. Interferon-gamma-induced apoptosis and activation of THP-1 macrophages. Life Sci 71 21 (2002) 2499-2508
83. Tamura T., Ueda S., Yoshida M., Matsuzaki M., Mohri H., and Okubo T. Interferon-gamma induces Ice gene expression and enhances cellular susceptibility to apoptosis in the U937 leukemia cell line. Biochem Biophys Res Commun 229 1 (1996) 21-26
84. Rosner D., Stoneman V., Littlewood T., McCarthy N., Figg N., Wang Y., et al. Interferon-gamma induces Fas trafficking and sensitization to apoptosis in vascular smooth muscle cells via a PI3K- and Akt-dependent mechanism. Am J Pathol 168 6 (2006) 2054-2063
85. Bai Y., Ahmad U., Wang Y., Li J.H., Choy J.C., Kim R.W., et al. Interferon-gamma induces X-linked inhibitor of apoptosis-associated factor-1 and Noxa expression and potentiates human vascular smooth muscle cell apoptosis by STAT3 activation. J Biol Chem 283 11 (2008) 6832-6842
86. Gimbrone Jr. M.A. Vascular endothelium, hemodynamic forces, and atherogenesis. Am J Pathol 155 1 (1999) 1-5
87. Buono C., Come C.E., Stavrakis G., Maguire G.F., Connelly P.W., and Lichtman A.H. Influence of interferon-gamma on the extent and phenotype of diet-induced atherosclerosis in the LDLR-deficient mouse. Arterioscler Thromb Vasc Biol 23 3 (2003) 454-460
88. Nakagomi A., Freedman S.B., and Geczy C.L. Interferon-gamma and lipopolysaccharide potentiate monocyte tissue factor induction by C-reactive protein: relationship with age, sex, and hormone replacement treatment. Circulation 101 15 (2000) 1785-1791
89. Yokoyama M., Hirata K., Kawashima S., and Kawahara Y. Regulation of nitric oxide synthase gene expression by cytokines. J Card Fail 2 4 Suppl (1996) S179-S185
90. Conrad D.J., Kuhn H., Mulkins M., Highland E., and Sigal E. Specific inflammatory cytokines regulate the expression of human monocyte 15-lipoxygenase. Proc Natl Acad Sci U S A 89 1 (1992) 217-221
91. Koga M., Kai H., Yasukawa H., Yamamoto T., Kawai Y., Kato S., et al. Inhibition of progression and stabilization of plaques by postnatal interferon-gamma function blocking in ApoE-knockout mice. Circ Res 101 4 (2007) 348-356
92. Ranjbaran H., Wang Y., Manes T.D., Yakimov A.O., Akhtar S., Kluger M.S., et al. Heparin displaces interferon-gamma-inducible chemokines (IP-10, I-TAC, and Mig) sequestered in the vasculature and inhibits the transendothelial migration and arterial recruitment of T cells. Circulation 114 12 (2006) 1293-1300
93. Schonbeck U., and Libby P. Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents?. Circulation 109 21, Suppl. 1 (2004) II18-III26
94. Hakamada-Taguchi R., Uehara Y., Kuribayashi K., Numabe A., Saito K., Negoro H., et al. Inhibition of hydroxymethylglutaryl-coenzyme a reductase reduces Th1 development and promotes Th2 development. Circ Res 93 10 (2003) 948-956
95. Sadeghi M.M., Tiglio A., Sadigh K., O'Donnell L., Collinge M., Pardi R., et al. Inhibition of interferon-gamma-mediated microvascular endothelial cell major histocompatibility complex class II gene activation by HMG-CoA reductase inhibitors. Transplantation 71 9 (2001) 1262-1268
96. Wagner A.H., Gebauer M., Guldenzoph B., and Hecker M. 3-hydroxy-3-methylglutaryl coenzyme A reductase-independent inhibition of CD40 expression by atorvastatin in human endothelial cells. Arterioscler Thromb Vasc Biol 22 11 (2002) 1784-1789
97. Shimizu K., Aikawa M., Takayama K., Libby P., and Mitchell R.N. Direct anti-inflammatory mechanisms contribute to attenuation of experimental allograft arteriosclerosis by statins. Circulation 108 17 (2003) 2113-2120
98. Bensinger S.J., and Tontonoz P. Integration of metabolism and inflammation by lipid-activated nuclear receptors. Nature 454 7203 (2008) 470-477
99. Marx N., Kehrle B., Kohlhammer K., Grub M., Koenig W., Hombach V., et al. PPAR activators as antiinflammatory mediators in human T lymphocytes: implications for atherosclerosis and transplantation-associated arteriosclerosis. Circ Res 90 6 (2002) 703-710
100. Singh N.N., and Ramji D.P. The role of transforming growth factor-beta in atherosclerosis. Cytokine Growth Factor Rev 17 6 (2006) 487-499